Stay updated on Benralizumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Benralizumab in Chronic Urticaria Clinical Trial page
- Check4 days agoChange DetectedNo additions or deletions were recorded; the page content and structure appear unchanged. There are no new elements affecting the page's purpose.SummaryDifference0.0%

- Check12 days agoChange DetectedThe page's revision metadata was updated from v3.5.2 to v3.5.3, signaling an incremental update to the study record documentation.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded revision: v3.5.2; removed revision: v3.5.0.SummaryDifference0.0%

- Check33 days agoChange DetectedIQVIA Pty Ltd was added as a collaborator and Iqvia Pty Ltd was removed from the Collaborators and Investigators section. This updates the official list of organizations involved in the study.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision v3.5.0 was added and Revision v3.4.3 was removed.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Benralizumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in Chronic Urticaria Clinical Trial page.